The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackrock I&g Regulatory News (BRIG)

Share Price Information for Blackrock I&g (BRIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 188.50
Bid: 188.00
Ask: 189.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.532%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 188.50
BRIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

18 Nov 2019 17:32

BlackRock Income and Growth Investment Trust Plc - Portfolio Update

BlackRock Income and Growth Investment Trust Plc - Portfolio Update

PR Newswire

London, November 18

BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC
(LEI:5493003YBY59H9EJLJ16)
All information is at 31 October 2019 and unaudited.
Performance at month end with net income reinvested
One MonthThree MonthsOne YearThree YearsFive YearsSince 1 April 2012
Sterling
Share price-1.0%-0.5%12.2%18.4%40.2%94.3%
Net asset value-2.3%-2.2%7.4%16.6%39.2%80.0%
FTSE All-Share Total Return-1.4%-2.1%6.8%19.3%37.9%76.2%
Source: BlackRock

BlackRock took over the investment management of the Company with effect from 1 April 2012.

At month end
Sterling:
Net asset value - capital only:196.37p
Net asset value - cum income*:201.30p
Share price:198.00p
Total assets (including income):£50.2m
Discount to cum-income NAV:1.6%
Gearing:6.7%
Net yield**:3.5%
Ordinary shares in issue***:22,958,100
Gearing range (as a % of net assets)0-20%
Ongoing charges****:1.1%

* includes net revenue of 4.93 pence per share
** The Company’s yield based on dividends announced in the last 12 months as at the date of the release of this announcement is 3.5% and includes the 2018 final dividend of 4.40p per share declared on 20 December 2018 and paid to shareholders on 19 March 2019 and the 2019 interim dividend of 2.60p per share declared on 25 June 2019 and paid to shareholders on 27 August 2019.
*** excludes 9,975,832 shares held in treasury
**** Calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs for the year ended 31 October 2018.

Sector AnalysisTotal assets (%)
Pharmaceuticals & Biotechnology9.7
Oil & Gas Producers9.4
Life Insurance8.7
Media8.6
Banks7.4
Support Services7.4
Food Producers6.5
Financial Services6.4
Household Goods & Home Construction4.5
Travel & Leisure4.5
Tobacco3.6
Food & Drug Retailers3.5
Gas, Water & Multiutilities3.4
Mining3.0
Health Care Equipment & Services2.5
Industrial Engineering2.2
Mobile Telecommunications2.2
Nonlife Insurance1.8
Electronic & Electrical Equipment1.2
Construction & Materials0.9
General Retailers0.5
Beverages0.3
Net Current Assets1.8
------
Total100.0
======
Ten Largest Equity Investments
CompanyTotal assets (%)
Royal Dutch Shell 'B'6.1
AstraZeneca5.2
GlaxoSmithKline4.5
RELX4.2
Unilever3.8
British American Tobacco3.6
Tesco3.5
National Grid3.4
BP Group3.4
BHP3.0

Commenting on the markets, Adam Avigdori and David Goldman representing the Investment Manager noted:
Whilst the FTSE All-Share fell by 1.4% in October, other global equity markets saw modest growth. Broad trends of slowing economic activity and uncertainty regarding US-China trade dominated headlines, while hopes of further easing offset this negative rhetoric. The most notable change in the month was around UK domestic assets, as Boris Johnson returned from Europe with a new deal and the risk of ‘no-deal’ Brexit diminished. This led to a rally in sterling and domestic shares outperforming, despite a challenging trading environment for UK businesses as the uncertainty around politics has impacted economic activity and decision making. The Company is broadly neutrally positioned in domestic names, albeit that the initial market reaction was in the domestic sectors that had previously been the most hard-hit (such as retail, property, banks). The Company’s exposure continues to be focused on franchises where we see substantial and sustainable long-term growth performance, and it did consequently see some underperformance in the month. Within the UK more broadly, companies with international exposure saw weakness, in some cases in spite of returning solid Q3 results to the market. Over the month, the Company detracted -2.2%, underperforming the benchmark, the FTSE All-Share by -0.8%. Smith & Nephew was the largest detractor to performance, when, despite strong trading results, the well-regarded CEO announced his departure. Hiscox also detracted on fears of claims from typhoons Faxai and Hagibis. The largest contributor to the fund was Ferguson, benefiting from strong trading and continued activist involvement. St James’ Place contributed to performance, reporting strong net inflows for the quarter. During the month we received shares as a result of the Prudential split into M&G, but we also added to the position. We sold our position in Elementis. We reduced our position in Taylor Wimpey given the recent strength in both shares. We added to our position in AB Foods given an increasingly attractive valuation. We also added to Unilever following recent share price weakness. We continue to see a period of sustained growth. Importantly, we expect nominal growth to remain modest as we see structural pressures from demographics, corporate underinvestment and new technology continuing to act as a drag on inflation. The dovish tilt from central banks is clearly supportive for markets, however from time-to-time we expect markets to worry about a shift to a more hawkish stance. With heightened political uncertainty and investor nervousness, we expect volatility to return to markets. This provides us, as active managers of a concentrated portfolio, with a great opportunity to identify high-quality cash generative businesses, with robust balance sheets, that can weather various market cycles and help to deliver long-term capital and income growth for our clients. We continue to like cash generative consumer staple companies, especially those exposed to the emerging market consumer given the prevalent demographic trends in certain markets. These companies often generate substantial cash flow which allows them to invest in innovation, marketing and distribution to ensure the longevity of their brands while also paying attractive and growing dividends to shareholders. We have also sought exposure to infrastructure spend whilst at the same time we are watching for signs of overheating in the US and monitoring economic growth in China. We also note that inflationary pressures are starting to build and therefore we seek those companies with sufficient pricing power and efficiency potential to withstand rising costs. As the recent past has demonstrated, it is crucial to be selective and to focus on those companies that are strong operators, that provide a differentiated service or product and that boast a strong balance sheet. 
18 November 2019
Date   Source Headline
3rd May 202412:13 pmPRNNet Asset Value(s)
2nd May 202412:10 pmPRNNet Asset Value(s)
2nd May 20247:00 amPRNTotal Voting Rights
1st May 202412:10 pmPRNNet Asset Value(s)
1st May 20247:00 amPRNTotal Voting Rights
30th Apr 20244:04 pmPRNTransaction in Own Shares
30th Apr 202412:07 pmPRNNet Asset Value(s)
29th Apr 20245:02 pmPRNTransaction in Own Shares
29th Apr 202412:25 pmPRNNet Asset Value(s)
29th Apr 20247:00 amPRNTotal Voting Rights
26th Apr 202411:45 amPRNNet Asset Value(s)
26th Apr 20247:00 amPRNTotal Voting Rights
25th Apr 20245:30 pmPRNTransaction in Own Shares
25th Apr 202412:14 pmPRNNet Asset Value(s)
24th Apr 20243:59 pmPRNTransaction in Own Shares
24th Apr 202412:15 pmPRNNet Asset Value(s)
23rd Apr 20244:44 pmPRNPortfolio Update
23rd Apr 202412:13 pmPRNNet Asset Value(s)
22nd Apr 202411:54 amPRNNet Asset Value(s)
19th Apr 202412:06 pmPRNNet Asset Value(s)
19th Apr 20247:00 amPRNTotal Voting Rights
18th Apr 202412:16 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 20246:03 pmPRNTransaction in Own Shares
17th Apr 202412:13 pmPRNNet Asset Value(s)
17th Apr 20247:00 amPRNTotal Voting Rights
16th Apr 20245:49 pmPRNTransaction in Own Shares
16th Apr 202412:02 pmPRNNet Asset Value(s)
16th Apr 20247:00 amPRNTotal Voting Rights
15th Apr 20245:10 pmPRNTransaction in Own Shares
15th Apr 202411:37 amPRNNet Asset Value(s)
15th Apr 20247:00 amPRNTotal Voting Rights
12th Apr 20244:32 pmPRNTransaction in Own Shares
12th Apr 202412:14 pmPRNNet Asset Value(s)
12th Apr 20247:00 amPRNTotal Voting Rights
11th Apr 20243:57 pmPRNTransaction in Own Shares
11th Apr 202412:11 pmPRNNet Asset Value(s)
11th Apr 20247:00 amPRNTotal Voting Rights
10th Apr 20245:18 pmPRNTransaction in Own Shares
10th Apr 202412:06 pmPRNNet Asset Value(s)
10th Apr 20247:00 amPRNTotal Voting Rights
9th Apr 20243:35 pmPRNTransaction in Own Shares
9th Apr 202411:45 amPRNNet Asset Value(s)
9th Apr 20247:00 amPRNTotal Voting Rights
8th Apr 20245:15 pmPRNTransaction in Own Shares
8th Apr 202411:59 amPRNNet Asset Value(s)
8th Apr 20247:00 amPRNTotal Voting Rights
5th Apr 20245:44 pmPRNTransaction in Own Shares
5th Apr 202412:15 pmPRNNet Asset Value(s)
5th Apr 20247:00 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.